Anti-Human VEGF Receptor 2 Therapeutic Antibody (Ramucirumab)
Recombinant monoclonal antibody to VEGF Receptor 2. Ramucirumab (IMC-1121B) is a fully human monoclonal antibody (IgG1) for the treatment of solid tumors. It is directed against the vascular endothelial growth factor receptor 2 (VEGFR2). By binding to VEGFR2 it works as a receptor antagonist blocking the binding of vascular endothelial growth factor (VEGF) to VEGFR2. VEGFR2 is known to mediate the majority of the downstream effects of VEGF in angiogenesis.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-079 |
| Pricing | Inquiry |
| Host | Human |
| Target | VEGF Receptor 2 |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | FC, IHC |
| Storage | 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided. |